期刊文献+

失代偿性肝硬化患者血清VEGF、TGF-β_1、TNF-α检测及临床意义 被引量:5

Detection and significance of serum VEGF,TGF-β_1,TNF-α in patients with decompensated liver cirrhosis
下载PDF
导出
摘要 目的:检测失代偿性肝硬化(DLC)患者血清血管内皮生长因子(VEGF)、转化生长因子β1(TGF-β1)、肿瘤坏死因子-α(TNF-α)水平,探讨血清VEGF、TGF-β1、TNF-α对DLC预后判断的意义。方法:选择DLC患者86例,同步测定血清VEGF、TGF-β1、TNF-α,分析三者水平变化与肝脏损伤程度的关系。结果:DLC患者血清VEGF、TGF-β1、TNF-α均明显高于健康组,随着肝硬化、肝癌发展,TGF-β1、TNF-α水平逐渐下降(P<0.05,P<0.01);发生慢加亚急性肝衰竭(SACLF)患者VEGF、TNF-α水平高于慢性肝衰竭(CLF)患者(P<0.05);中晚期SACLF患者VEGF、TNF-α高于早期,早中期患者TGF-β1水平低于晚期(P<0.05);死亡患者血清VEGF、TGF-β1水平明显高于病情好转者(P<0.01),TNF-α低于病情好转者(P<0.05)。结论:DLC患者血清VEGF、TGF-β1、TNF-α的水平与疾病的严重程度及预后密切相关,它们在DLC发生发展过程中可能起重要作用。 Objective:To evaluate the significance of serum vascular endothelial growth factor (VEGF),transforming growth factor-β1 (TGF-β1) and tumor necrosis factor-α (TNF-α) in predicting prognosis of patients with decompensated liver cirrhosis (DLC). Methods:Serum VEGF,TGF -β1,and TNF-α were detected in 86 patients with DLC. The correlations between the changes of serum VEGF ,TGF-β1 and TNF-α and the degree of liver injury were analyzed. Results:The serum levels of VEGF,TGF-β1 and TNF-α were all higher than those o...
出处 《南通大学学报(医学版)》 2009年第4期244-246,共3页 Journal of Nantong University(Medical sciences)
基金 南通市社会发展科技计划项目(S5016)
关键词 肝硬化 失代偿 血管内皮生长因子 转化生长因子Β1 肿瘤坏死因子-α Liver cirrhosis Decompensated Vascular endothelial growth factor Transforming growth factor -β1 Tumor necrosis factor-α
  • 相关文献

参考文献5

二级参考文献32

  • 1AZeuzem S, Carreno V. Interleukin-12 in the treatment of chronic hepatitis B and C. Antiviral Res 2001; 52:181-188.
  • 2Bradham CA, Plumpe J, Manns MP, Brenner DA, Tautwein C. Mechanisms of hepatic toxicity I. TNF-induced liver injury.Am J Physiol 1998; 275:387-392.
  • 3Schlaak JF, Tully G, L6hr HF, Gerken G. HBV-specific immune defect in chronic hepatitis B (CHB) is correlated with a dysregulation of pro-and anti-inflammatory cytokines. Clin Exp Immunol 1999; 115:508-514.
  • 4Jiang R, Feng X, Guo Y, Lu Q, Hou J, Luo K, Fu N. T helper cells in patients with chronic hepatitis B virus infection. Chin Med J 2002, 115: 422-424.
  • 5Kobayashi K, Ishii M, Igarashi T, Satoh T, Miyazaki Y, Yajima Y, Ukai K, Suzuki H, Kanno A, Ueno Y, Miura T, Toyota T.Profiles of cytokines produced by CD4-positive T lymphocytes stimulated by anti-CD3 antibody in patients with chronic hepatitis C. J Gastroenterol 1998; 33:500-507.
  • 6Atsukawa K,Saito H, Tsukada N, Akiba Y, Toda K, Kumagai N, Ohishi T, Kamegaya Y, Ishii H. Thl and Th2 cytokines differentially regulate the transformation of Kupffer cells into multinucleated giant cells but similarly enhance the Kupffer cell-induced hepatic stellate cell proliferation. Hepatology Res 2001; 20:193-206.
  • 7Hirohashi S, Ishak KG, Kojiro M, Wangless IR, Theise ND,Tsukuma H. Hepatocellular Carcinoma. Hamilton SR,Aaltonen LA. Pathology and Genetics Tumours of the Digestive System. First edition. Lyon: IARC 2000,159-172.
  • 8Schiirch W, Gurley AM, Roth SI. Myofibroblast. Sternberg SS. Histology for Pathologists. Second edition. Philadelphia:Lippincott Raven 1997,129-166.
  • 9Kweon Y, Goodman ZD, Diestang JL, Schiff ER, Brown NA,Burkhardt E. Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B. J Hepatol 2001; 35:749-755.
  • 10Neuman MG, Benhamou JP, Bourliere M, Ibrahim A,Malkiewicz I, Asselah T, Martinot-Peignoux M, Shear NH,Katz GG, Akremi R, Benali S, Boyer N, Lecomte L, Le Breton V, Le Guludec G, Marcellin P. Serum tumor necrosis factor-α and transforming growth factor-β levels in chronic hepatitis C patients are immunomodulated by therapy. Cytokine 2002;17:108-117.

共引文献14065

同被引文献62

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部